SCHEMBL5157376

SCHEMBL5157376

O=[C]OC(C(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.64
CYP3A4 P08684 3/20 0.64
TDP1 Q9NUW8 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
LMNA P02545 4/20 0.50
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
POLB P06746 2/20 0.49
MAPT P10636 2/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.44
NPSR1 Q6W5P4 3/20 0.42
ADRB2 P07550 1/20 0.41
MDM2 Q00987 1/20 0.39
CYP2C19 P33261 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9030101 0.86 ALDH1A1 (0.49) ALDH1A1CYP3A4TDP1L3MBTL1MEN1
SCHEMBL710572 0.82 CYP2D6 (0.46) ALDH1A1CYP3A4TDP1L3MBTL1LMNA
SCHEMBL159213 0.82 ALDH1A1 (0.69) ALDH1A1CYP3A4TDP1L3MBTL1LMNA
SCHEMBL30283 0.80 ALDH1A1 (0.67) ALDH1A1CYP3A4TDP1L3MBTL1LMNA
SCHEMBL8103707 0.80 ALDH1A1 (0.45) ALDH1A1CYP3A4TDP1L3MBTL1LMNA
SCHEMBL9068581 0.79 ALDH1A1 (0.51) ALDH1A1CYP3A4L3MBTL1LMNAKMT2A
SCHEMBL8916696 0.79 ALDH1A1 (0.65) ALDH1A1CYP3A4TDP1L3MBTL1LMNA
Water SCHEMBL9512888 0.79 ALDH1A1 (0.65) ALDH1A1CYP3A4TDP1L3MBTL1LMNA
SCHEMBL337104 0.78 ALDH1A1 (1.00) ALDH1A1CYP3A4TDP1L3MBTL1LMNA
SCHEMBL8166476 0.77 ALDH1A1 (0.62) ALDH1A1CYP3A4TDP1L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0101149-A1 Fluoroalkyl indoline derivatives for pharmaceutical use IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1984-02-22 EP claimed
US-8350043-B2 Azinone and diazinone V3 inhibitors for depression and stress disorders PHARMACOPEIA, INC. (US) 2013-01-08 US disclosed
US-20070037822-A1 Azinone and diazinone V3 inhibitors for depression and stress disorders PHARMACOPEIA DRUG DISCOVERY, INC. (US) 2007-02-15 US disclosed
EP-1622898-A1 PROCESSES FOR MAKING THIAZOLIDINEDIONE DERIVATIVES AND COMPOUNDS THEREOF Synthon B.V. (NL) 2006-02-08 EP disclosed
US-20050059708-A1 Processes for making thiazolidinedione derivatives and compounds thereof SYNTHON BV (NL) 2005-03-17 US disclosed
WO-2004101560-A1 PROCESSES FOR MAKING THIAZOLIDINEDIONE DERIVATIVES AND COMPOUNDS THEREOF SYNTHON B.V. (NL) 2004-11-25 WO disclosed
CN-1202893-A Novel isoxazoline and isoxazole fibrinogen receptor antagonists DU PONT MERCK PHARMA (US) 1998-12-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059708-A1 Processes for making thiazolidinedione derivatives and compounds thereof PPARD, PPARG, PPARA ALDH1A1 612/4885CYP3A4 28/4885TDP1 3777/4885
US-20070037822-A1 Azinone and diazinone V3 inhibitors for depression and stress disorders HTR3C, HTR3A, AZI2 ALDH1A1 200/4885CYP3A4 783/4885TDP1 3091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.